The association between LOC111413029 (BRD4-Independent Group 4 Enhancer GRCh37_chr16:71605697-71606896) and Tyrosinemia, Type Ii is supported by expert-curated evidence, drawing on a single expert-curated source, which records likely-pathogenic variants.
Sources1
Clinical variants80
Symptoms36
Compounds0
Trials0
Publications5
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.